Other Stories

KCDC to answer on whether Remdesivir can be used for COVID-19 treatment Updated: 2020-05-29 10:06:39 KST

South Korea is likely to officially accept the use of Remdesivir, an Ebola treatment that has emerged as a new hope in tackling COVID-19.
According to sources, a group of infectious disease experts agreed on Thursday to recommend use of the drug to the nation's quarantine authorities.
Their message also contained information on how to properly and effectively use it to fight COVID-19.
The Korea Centers for Disease Control and Prevention will announce their answer during Friday's daily briefing.
According to the U.S. National Institutes of Health, Remdesivir has successfully shortened the median recovery time fopr COVID-19 from fifteen days to eleven.
Reporter : tkim@arirang.com
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.